Sam Ringle is a seasoned Regulatory Affairs consultant supporting pharmaceutical and biotechnology companies across the EU and US. With a scientific background in genetics and biochemistry and nine years of hands-on experience across small molecules, biologics, and cell and gene therapies, he helps teams translate complex science into clear, regulator-ready development strategies.

Sam advises early-stage start-ups as well as established developers on regulatory planning, scientific advice interactions, clinical trial applications, and lifecycle strategy. He is known for his pragmatic, risk-based approach and early engagement with regulatory authorities to de-risk and accelerate development programs.

Through Ringle Regulatory Services, Sam acts as a strategic partner, bridging innovation and regulation to support efficient, patient-focused product development.